Hamburger Menu Button
Thermo Fisher Scientific Logo
登录
没有账号?建立账号 注册
  • 产品
    • 抗体
    • 引物合成
    • GeneArt Gene Synthesis Instant Designer
    • TaqMan Assay and Array Search
    • PCR 设备和耗材
    • 色谱柱和纯化柱
    • 实验室离心机
    • 分子生物学试剂和试剂盒
    • 实验室塑料耗材及用品
    • 查看所有产品分类
  • 应用和技术
    • 色谱
    • 细胞转染和培养
    • 实时荧光定量PCR
    • 质谱
    • 实验室塑料耗材及用品
    • 电子显微镜
    • 蛋白质生物学
    • PCR
    • RNAi
    • 环境
    • 查看所有应用和技术
  • 服务
    • 定制服务
    • 企业级实验室信息化服务
    • 企业服务
    • 金融&租赁服务
    • 仪器服务
    • OEM和商业供应
    • 培训服务
    • 360° CDMO 和 CRO 服务
    • CDMO 服务
    • 临床试验 CRO 服务
    • 查看所有帮助和支持
  • 帮助和支持
    • 学习中心
    • 联系我们
    • 更改国家或地区
    • 查看所有帮助和支持
  • 热门产品
    • TaqMan Real-Time PCR Assays
      TaqMan 实时荧光定量 PCR 试剂盒
    • Antibodies
      抗体
    • Oligos, Primers & Probes
      寡核苷酸、引物、探针
    • GeneArt Gene Synthesis
      GeneArt 基因合成
    • Cell Culture Plastics
      细胞培养耗材
  • 联系我们
  • 货号直购
  • 订单查询
  • 查找文件&证书
Thermo Fisher Scientific Logo

Search

搜索全部或下列指定分类
Search button
          • 联系我们
          • 货号直购
          • 登录
            登录
            没有账号?建立账号 注册
            • 我的账号
            • 订单
            • 账单及发票查询
            • 定制产品及项目

          Advancing analytical workflows for prohibited substance detection in equine athletes using software tools

          • Overview
          • About the presenters

          Despite advances in analytical chemistry, it is becoming increasingly challenging to control prohibited substance abuse in equine athletes. A problem is the ever-increasing number of prohibited substances, resulting in the need for large custom-made compound databases and mass spectral libraries.

          In this webinar, we discuss the development of a >440 compound screen, with a custom-built mass spectral library and compound database along with the transfer of this method from a Thermo Scientific Orbitrap Exploris 480 MS to a Thermo Scientific TSQ Altis mass spectrometer for confirmation. We demonstrate the integration of multiple software tools including mzCloud, mzVault and Thermo Scientific TraceFinder SW for a holistic view of method development beyond analytical capabilities.

          Key learning objectives

          • Understand the analytical challenges of confidently detecting and identifying prohibited substances
          • Discover how integrated software tools can drive rapid method development from a discovery environment, through to routine screening and confirmation
          • See how connected hardware platforms and software tools aid in method transfer, and help to advance analytical workflows to combat the issues of prohibited substance detection
          • Better understand how a connected laboratory is now a reality, and can help with small molecule compound identification and quantitation workflow deployment

          Who should attend

          Researchers and leaders in Academia, bio/pharma, clinical, forensic toxicology, and protein research; any laboratories who are focused on both small molecule and protein identification and quantitation workflows, where there is the need to transfer knowledge from research through to routine.

          • Lab Directors and industry experts responsible for setting new standards, and when needed, demonstrate success in challenging or high-profile work.
          • Technology Leaders responsible for the competitive edge while improving productivity and efficiency with highly trained operators.
          • Principle Scientists in screening and quantitative applications: needing the best technology to advance their research discoveries and develop new testing methodologies.
          Scott Stanley, Ph.D., Professor in Equine Toxicology and Pharmacology, Department of Veterinary Science and Director of the Equine Analytical Chemistry Laboratory, University of Kentucky

          Scott Stanley, Ph.D., Professor in Equine Toxicology and Pharmacology, Department of Veterinary Science and Director of the Equine Analytical Chemistry Laboratory, University of Kentucky

          Dr. Stanley received his doctoral degree in Toxicology in 1992, and his bachelor’s degree in Animal Science in 1988 from the University of Kentucky. He was a faculty member at University of California-Davis since 1997 through 2018. At UC-Davis, Dr. Stanley was the chief chemist of the Kenneth L. Maddy Equine Analytical Chemistry Laboratory. He modernized drug testing in California horse racing by introducing new, state-of-the-art instrumental drug testing equipment and procedures. He has also worked closely with manufactures in adapting newer technologies to equine drug testing. Dr. Stanley moved to the University of Kentucky in early 2019, his current research interests are related to drug testing methods for the detection of biopharmaceuticals, natural products and designer drugs, and the establishment of the Equine Biological Passport project.

          Sophie Bromilow, Ph.D., Scientist III at Equine Analytical Research Laboratory, University of Kentucky

          Sophie Bromilow, Ph.D., Scientist III at Equine Analytical Research Laboratory, University of Kentucky

          Dr. Bromilow received her doctoral degree in Biology, Medicine and Health focused on Proteomics in 2018 from the University of Manchester, and her bachelor’s degree in Chemistry 2013 from the University of Liverpool. Following the completion of her Ph.D Dr. Bromilow joined UC Davis under Dr. Stanley’s supervision to undertake Post-Doctoral Research. During this time, Dr. Bromilow applied her proteomics expertise to Equine Anti-Doping Strategies and began to establish the Equine Biological Passport, showing the first proof of concept for the use of biomarkers as indicators of prohibited substance abuse. Dr. Bromilow has since continued her research under Dr. Stanley’s supervision at the University of Kentucky.

          Overview

          Despite advances in analytical chemistry, it is becoming increasingly challenging to control prohibited substance abuse in equine athletes. A problem is the ever-increasing number of prohibited substances, resulting in the need for large custom-made compound databases and mass spectral libraries.

          In this webinar, we discuss the development of a >440 compound screen, with a custom-built mass spectral library and compound database along with the transfer of this method from a Thermo Scientific Orbitrap Exploris 480 MS to a Thermo Scientific TSQ Altis mass spectrometer for confirmation. We demonstrate the integration of multiple software tools including mzCloud, mzVault and Thermo Scientific TraceFinder SW for a holistic view of method development beyond analytical capabilities.

          Key learning objectives

          • Understand the analytical challenges of confidently detecting and identifying prohibited substances
          • Discover how integrated software tools can drive rapid method development from a discovery environment, through to routine screening and confirmation
          • See how connected hardware platforms and software tools aid in method transfer, and help to advance analytical workflows to combat the issues of prohibited substance detection
          • Better understand how a connected laboratory is now a reality, and can help with small molecule compound identification and quantitation workflow deployment

          Who should attend

          Researchers and leaders in Academia, bio/pharma, clinical, forensic toxicology, and protein research; any laboratories who are focused on both small molecule and protein identification and quantitation workflows, where there is the need to transfer knowledge from research through to routine.

          • Lab Directors and industry experts responsible for setting new standards, and when needed, demonstrate success in challenging or high-profile work.
          • Technology Leaders responsible for the competitive edge while improving productivity and efficiency with highly trained operators.
          • Principle Scientists in screening and quantitative applications: needing the best technology to advance their research discoveries and develop new testing methodologies.
          About the presenters
          Scott Stanley, Ph.D., Professor in Equine Toxicology and Pharmacology, Department of Veterinary Science and Director of the Equine Analytical Chemistry Laboratory, University of Kentucky

          Scott Stanley, Ph.D., Professor in Equine Toxicology and Pharmacology, Department of Veterinary Science and Director of the Equine Analytical Chemistry Laboratory, University of Kentucky

          Dr. Stanley received his doctoral degree in Toxicology in 1992, and his bachelor’s degree in Animal Science in 1988 from the University of Kentucky. He was a faculty member at University of California-Davis since 1997 through 2018. At UC-Davis, Dr. Stanley was the chief chemist of the Kenneth L. Maddy Equine Analytical Chemistry Laboratory. He modernized drug testing in California horse racing by introducing new, state-of-the-art instrumental drug testing equipment and procedures. He has also worked closely with manufactures in adapting newer technologies to equine drug testing. Dr. Stanley moved to the University of Kentucky in early 2019, his current research interests are related to drug testing methods for the detection of biopharmaceuticals, natural products and designer drugs, and the establishment of the Equine Biological Passport project.

          Sophie Bromilow, Ph.D., Scientist III at Equine Analytical Research Laboratory, University of Kentucky

          Sophie Bromilow, Ph.D., Scientist III at Equine Analytical Research Laboratory, University of Kentucky

          Dr. Bromilow received her doctoral degree in Biology, Medicine and Health focused on Proteomics in 2018 from the University of Manchester, and her bachelor’s degree in Chemistry 2013 from the University of Liverpool. Following the completion of her Ph.D Dr. Bromilow joined UC Davis under Dr. Stanley’s supervision to undertake Post-Doctoral Research. During this time, Dr. Bromilow applied her proteomics expertise to Equine Anti-Doping Strategies and began to establish the Equine Biological Passport, showing the first proof of concept for the use of biomarkers as indicators of prohibited substance abuse. Dr. Bromilow has since continued her research under Dr. Stanley’s supervision at the University of Kentucky.

          Register to view the free
          on-demand webinar

          * Required field

          *
          *
          *
          *
          *
          *
          *
          *
          *
          *

           I would like to speak with an expert to learn how Thermo Fisher Scientific products can help in my laboratory
           Please confirm you would like to receive marketing and promotional email messages about Thermo Fisher Scientific products and services.
           
           

          Resources

          • Learn more about the Orbitrap Exploris 480 mass spectrometer
          • eBook: Strategies for Making Small Molecule Unknowns Known
          • Watch more LC-MS webinars
          • Technical Note: Building Curated and Annotated HRAM MSn Spectral Libraries to Aid in Unknown Structure Elucidation
          • White Paper: Delivering confidence for small molecule Identification
          • Smart Note: Accelerate small-molecule unknown identification
          订购 Plus Icon Minus Icon
          • 订单状态查询
          • 订单支持
          • 货号直购
          • 现货供应中心
          • 电子采购
          支持 Plus Icon Minus Icon
          • 帮助&支持
          • 联系我们 - 400 820 8982
          • 技术支持中心
          • 查找文件&证书
          • 报告网站问题
          资源 Plus Icon Minus Icon
          • 学习中心
          • 促销
          • 活动&研讨会
          • 社交媒体
          关于赛默飞 Plus Icon Minus Icon
          • 关于我们
          • 招聘 招聘
          • 投资者关系 投资者关系
          • 新闻 新闻
          • 社会责任 社会责任
          • 商标
          • 政策和通知
          品牌 Plus Icon Minus Icon
          • Thermo Scientific
          • Applied Biosystems
          • Invitrogen
          • Gibco
          • Ion Torrent
          • Patheon
          • PPD
          • 服务条款
          • 隐私政策
          • 定价和运输保险政策
          © 2006-2025 Thermo Fisher Scientific Inc. All rights reserved. All trademarks are the property of Thermo Fisher Scientific and its subsidiaries unless otherwise specified.
          China flag icon
          China
          本网站销售的所有产品均不得用于人类或动物之临床诊断或治疗,仅可用于工业或者科研等非医疗目的。
             电子营业执照 | 经营证照公示 | ICP备案号:沪ICP备11003924号 | 沪公网安备 31011502006935号